Feedback plc
Update re Bleepa®
Cambridge, 17 October 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, is pleased to provide an update on Bleepa®.
The Company is considering a number of potential opportunities for Bleepa® following its launch at the NHS Expo in September 2019. The Company is in advanced discussions with NHS pilot sites whilst additionally pursuing a number of commercial opportunities within and outside the NHS, and hopes to commence Bleepa® pilot schemes in the near future.
To date, the Bleepa® product has been well received by the healthcare community and the Company believes that it will enable a number of healthcare providers to provide faster, safer, more efficient care. The Company looks forward to providing further updates in due course.
Tom Oakley, CEO of Feedback plc, said:
"We are very encouraged by the response to Bleepa® having discussed this with senior NHS executives and clinicians at NHS Expo. The feedback that we have received is that Bleepa® clearly has applications across the healthcare sector, not only in individual hospital settings but also in community and cross site clinical settings. We look forward to making further announcements in relation to Bleepa®, in due course."
The Company continues to progress with its strategic review of TexRAD®, a longstanding part of the Feedback portfolio. The Company hopes to complete the strategic review by the end of the calendar year.
-Ends-
Enquiries:
Feedback plc Tom Oakley, CEO Lindsay Melvin, CFO |
+44 (0)1954 718072 [email protected] |
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai |
+44 (0)20 3328 5656 |
Peterhouse Capital Limited (Joint Broker) Lucy Williams / Duncan Vasey |
+44 (0)20 7469 0936 |
Stanford Capital Partners Limited (Joint Broker) Patrick Claridge / John Howes |
+44 20 3815 8880 |
Instinctif Partners Rozi Morris / Phillip Marriage |
+44 (0)20 7457 2020 [email protected] |
Notes to editors
About Feedback plc - www.fbk.com
Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.
Feedback has launched Bleepa®, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa®, see www.bleepa.com.
